Avestria Ventures
Investor type
PE / VC
Founded
2018
AUM
$200 M
Location
San Francisco, California, United States
$0-1 m
Investment Ticket
5-7 years
Investment Horizon
Seed,
Series A
Investment Stage
Sale to strategic investor,
IPO,
M&A
Exit Strategy
Profile
We seek out early stage businesses with a product or service that utilizes technology and/or data to improve the quality of healthcare, improve access, lower costs or empower patients. In order to achieve commercial success, these businesses must be evidenced-based, induce clinical or behavioral change, possess scalable commercialization plans which account for healthcare policy, reimbursement and the existing infrastructure, and possess a sustainable competitive advantage.
Industry
Region of investment
Avestria Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Avestria Ventures Fund I
|
Venture Capital (VC)
|
Biotechnology
Digital
Healthcare Services
Medical Devices
HealthTech
|
Seed
Series A
|
North America
|
$5-10 m
|
$50 M
|
July 2019
|
|
Avestria Ventures Fund II
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
|
Seed
Series A
|
North America
|
$5-10 m
|
$100 M
|
June 2022
|
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!